RgIA vs ALRN-6924

Head-to-head comparison of RgIA (alpha-Conotoxin RgIA from Conus regius venom) and ALRN-6924 (ALRN-6924 dual MDM2/MDMX stapled p53 mimetic peptide) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyRgIAALRN-6924
CategoryExperimentalExperimental
Full Namealpha-Conotoxin RgIA from Conus regius venomALRN-6924 dual MDM2/MDMX stapled p53 mimetic peptide
Molecular Weight1,670 DaN/A
Half-LifeMinutes to hoursHours to days depending on formulation
Amino Acids13N/A
Typical Dose10-300 pmol intrathecal|1-100 nM in vitro|single-dose rodent studiesVaries by clinical protocol
RouteIntrathecalIntravenous/Subcutaneous
Purity≥98%≥98%
Studies Count13040
Research StatusPre-clinicalClinical

RgIA Benefits

  • alpha9alpha10 nAChR selectivity
  • neuropathic pain model tool
  • neuroimmune signaling research
  • analgesic lead discovery

ALRN-6924 Benefits

  • p53 reactivation
  • dual MDM2/MDMX inhibition
  • protease resistance
  • tumor cell apoptosis

RgIA Dosing

Intrathecal bolus in rodent pain models|Patch-clamp assays on alpha9alpha10 receptors|Single-dose pre-clinical screening

ALRN-6924 Dosing

Clinical trial protocol dosing|Intermittent administration|Research-only escalation

RgIA Side Effects

  • Transient autonomic effects
  • off-target nicotinic blockade
  • injection-site irritation

ALRN-6924 Side Effects

  • nausea
  • fatigue
  • myelosuppression

Research Overview

RgIA

Scientific studies show RgIA can strongly inhibit alpha9alpha10 nicotinic signaling with high selectivity compared with many other nAChR ligands. It is widely used to probe peripheral sensory pathways and inflammation-linked pain mechanisms.

ALRN-6924

ALRN-6924 is one of the best-known stapled peptide therapeutics and has advanced into human oncology studies. Literature shows that hydrocarbon stapling can improve target affinity, serum stability, and cellular activity for this p53-mimetic scaffold.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

RgIA stacks with:

gabapentinpregabalinduloxetine

ALRN-6924 stacks with:

venetoclaxcisplatindoxorubicin
cone-snailvenom-peptidenicotinic-receptorpain-researchstapled-peptidep53mdm2mdmxoncology